Misbranding of Ayurvedic pharmaceutical preparations A market survey report
AbstractBackground: The annual turnover of the Indian herbal medicinal industry is about Rs. 7,500 crore as against the pharmaceutical industry’s turnover of Rs. 14,500 crores with a growth rate of more than 15%. Certainly some regulations are required to keep a check on this massive industry. Drugs and Cosmetics Act, 1940 (D& C Act) lays down the regulatory and recommendatory standards for Ayurvedic drugs. Objective: The present survey study was undertaken to assess the compliance of the D & C Act by the Ayurveda drugs manufacturing units. The guidelines laid down by this act formed the basis of the study. Materials & Methods: A total of 100 drug labels from 13 different major pharmaceutical houses were collected from the market and analysed on the basis of guidelines for labelling laid down under D&C Act, 1940. Results: It was found that none of the labels satisfied all the guidelines pertaining to labelling standards of the Ayurvedic drugs. It was observed that 92% drug labels did not mention the API standards of the drugs used while 99% drug labels did not mention the part of the plant used. Conclusions: It was inferred that potentially large number of the Ayurvedic drugs being marketed in India are misbranded.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.